The Sarcoma Steering Committee (Sarcoma SC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult sarcomas. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The Sarcoma SC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Chair
Lara E. Davis, M.D.
Fred Hutchinson Cancer Center
Members
Annie J. Achee
National Leiomyosarcoma Foundation
James Robert Anderson, Ph.D.
University of Nebraska Medical Center
Shantanu Banerji, M.D., FRCPC
CancerCare Manitoba
Kenneth Cardona, M.D.
Emory University
Sandra D'Angelo, M.D.
Memorial Sloan Kettering Cancer Center
Hari A. Deshpande, M.D.
Yale University / Smilow Cancer Hospital
Boris Freidlin, Ph.D.
National Cancer Institute
Leonard Henry, M.D., M.B.A.
Nancy N. and J.C. Lewis Cancer and Research Pavilion
Mariam Jafri, Ph.D., M.B.Ch.B.(Hons), M.Sc.
Queen's University
Anusha Kalbasi, M.D.
Stanford University
Joshua Matthew Varghise Mammen, M.D., Ph.D., M.B.A., M.Ed.
University of Nebraska
Sumithra J. Mandrekar, Ph.D.
Mayo Clinic
Margaret M. Mooney, M.D., M.B.A.
National Cancer Institute
Richard Francis Riedel, M.D.
Duke Cancer Institute
Steven Ian Robinson, M.B.B.S.
Mayo Clinic Rochester
Gary K. Schwartz, M.D.
Case Western Reserve University
Nita Seibel, M.D.
National Cancer Institute
Brittany Lynn Siontis, M.D., M.S.
Mayo Clinic
Dian Wang, M.D., Ph.D.
Rush University Medical Center
Jeanette C. Yu, M.D., M.P.H.
The Permanente Medical Group
NCI CCCT Program Director
Ramy Serour, M.S.
ramy.serour@nih.gov